Male or female subjects must have been between 2 and 60 years of age at the time of the enrollment in the Phase 3 double-blind study 13110A/OV1012/NCT00518713 or between 2 and 30 years of age at the time of the enrollment in the Phase 2 double-blind study 13108A/OV1002/NCT00162981 study 